Carregant...
Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD
The Coronavirus 2019 (COVID-19) pandemic has posed challenges in the routine care of patients with inflammatory bowel disease. One of the key challenges needing addressing is the quantification of the risks of immunosuppressive and biologic therapies in IBD patients during the pandemic. The similari...
Guardat en:
| Publicat a: | J Crohns Colitis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7314090/ https://ncbi.nlm.nih.gov/pubmed/32520312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjaa120 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|